Reply to Questions Posed by the House Veterans Affairs Committee regarding Gulf War Illnesses

According to the AP. in the US, “the government placed three orders last year for a combined total of nearly 200 million doses — an unprecedented amount and almost double the amount of vaccine made in recent years for seasonal flu.“ About a quarter of the swine flu vaccine produced for the U.S. public has…

UPDATE:  I just learned that in 2008 GSK obtained European regulatory approval to market a so-called “Prepandemic” Vaccine for H5N1 avian flu.  This virus is not circulating in humans.  The theory behind the vaccine is that if a bird flu virus emerged to cause a pandemic, the GSK vaccine is likely to be somewhat similar to it,…

Senator Lankford of Oklahoma discusses the effect of the mandates on his constitutents and perhaps a new currency system? https://www.brighteon.com/2cfb6c87-5a05-42c3-8a84-2f57b2f575ab

I love the Lancet. I have my own subscription, and it isn’t cheap. However, the Lancet took a cheap shot last week, when it retracted a paper on autism by Wakefield et al. immediately following a ruling by the UK’s General Medical Counsel. The Lancet has been embroiled in controversy (and repeatedly tried to extract…

From Politico, this story of how over $100,000 was spent to dig up dirt on the head of FDA’s Center for Drug Evaluation and Research: For more than two months in late 2008, private investigators working for a drug company gathered information on a high-ranking official at the Food and Drug Administration — unearthing details about…

An excellent article digging into the details of licensing Covid vaccines, by Peter Doshi: Covid-19 vaccines: In the rush for regulatory approval, do we need more data? BMJ 2021; 373 doi: https://doi.org/10.1136/bmj.n1244 (Published 18 May 2021) After rollout under emergency authorisation, manufacturers of covid-19 vaccines now have their sights on regulatory approval. But what’s the rush, asks Peter Doshi, and is…